This topic contains a solution. Click here to go to the answer

Author Question: Generalized anxiety disorder is a condition characterized by excessive anxiety and worry that ____. ... (Read 44 times)

leilurhhh

  • Hero Member
  • *****
  • Posts: 560
Generalized anxiety disorder is a condition characterized by excessive anxiety and worry that ____.
 
  a. includes panic attacks and phobias
  b. disrupts daily life
  c. affects most of the general population
  d. is not correlated with particular objects or situations

Question 2

Which of the following is true of anxiety?
 
  a. People appear to have genetic vulnerabilities to specific types of anxiety disorders.
  b. Evidence of a predisposition to anxiety appears early in life.
  c. Children first show anxiety to novel situations around the time they start to crawl.
  d. Highly reactive infants are usually calm by the time they are 4 or 5 years old.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

connor417

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

ANSWER:
d

Answer to Question 2

ANSWER:
b




leilurhhh

  • Member
  • Posts: 560
Reply 2 on: Jun 19, 2018
:D TYSM


dawsa925

  • Member
  • Posts: 326
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

No drugs are available to relieve parathyroid disease. Parathyroid disease is caused by a parathyroid tumor, and it needs to be removed by surgery.

Did you know?

There are more bacteria in your mouth than there are people in the world.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

HIV testing reach is still limited. An estimated 40% of people with HIV (more than 14 million) remain undiagnosed and do not know their infection status.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library